Olmesartan Medoxomil and Diabetic Nephropathy

Clinical trial NCT00362960 · COMPLETED

Trial details

NCT number: NCT00362960
Sponsor: Sankyo Pharma Gmbh
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Diabetic Nephropathy Proteinuria Renal Disease

Start date: 2003-05-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.